logo.gif (5118 bytes)
`
Scientific Program
Main Topics
Committees
Sponsors
Exhibition

SCIENTIFIC PROGRAM

WEDNESDAY, MARCH 21, 2001 THURSDAY, MARCH 22, 2001 FRIDAY, MARCH 23, 2001 SATURDAY, MARCH 24, 2001 SUNDAY, MARCH 25, 2001
    POSTER SESSIONS 1       
      POSTER SESSIONS 2

In order to view the abstracts of the presentations below, please click 
on the abstract titles highlighted in blue

FRIDAY, MARCH 23, 2001
08:30-10:00
LASER GLAUCOMA THERAPY
SLT - A NEW HOPE FOR FIRST LINE GLAUCOMA TREATMENT
Sponsored by Coherent Medical Group
Chairperson: J. A Alvarado, USA
Hall A
08:30  SELECTIVE LASER TRABECULOTHERAPY (SLT) - UNITED STATES PROSPECTIVE MULTI-CENTER CLINICAL TRIAL RESULTS
M.A. Latina, J.A. Tumbocon, R.J. Noecker, D.H. Shin, R. Ritch, G. Marcellino, USA
 
08:42  SELECTIVE LASER TRABECULOPLASTY-HOW DOES IT WORK?
J.A. Alvarado, USA
 
08:54  SELECTIVE LASER TRABECULOPLASTY - A NEW TREATMENT FOR GLAUCOMA
F.W. Howes, M. Nagar, England, New Zealand
 
09:06  SELECTIVE LASER TRABECULOPLASTY VS ARGON LASER TRABECULOPLASTY: A RANDOMIZED CLINICAL TRIAL
K.F. Damji, Canada
 
09:18  A COMPARISON OF THE INTRAOCULAR PRESSURE REDUCING EFFECT OF SELECTIVE LASER TRABECULOPLASTY AND ARGON LASER TRABECULOPLASTY IN PATIENTS WITH GLAUCOMA
L.I. Larsson, Sweden
 
09:30  MICROPULSE TRANSSCLERAL CYCLOPHOTOCOAGULATION IN THE TREATMENT OF REFRACTORY GLAUCOMA
C.L. Ho, Singapore
 
09:35  LASER CYCLOPHOTOCOAGULATION IN EYES WITH AMBULATORY VISION
J.T. Wilensky, J.A. Kammer, USA
 
09:40  APPLICATION OF ERBIUM: YAG LASER IN NON-PENETRATING DEEP SCLERECTOMY WITH RETICULATED HYALURONIC ACID IMPLANT
P. Rusek, S. Bolek, Poland
 
09:45 LASER DEEP SCLERECTOMY
V.P. Kozobolis, Greece
 
09:55  Discussion  
10:00  Coffee Break  
10:30-12:00 
CO-REGULATION - A COMPREHENSIVE APPROACH FOR GLAUCOMA
Sponsored by Merck, Sharp & Dohme
Chairperson:
J. Flammer, Switzerland
Hall A
10:30  OPENING COMMENTS
J. Flammer, Switzerland
 
10:35  OPTIC NERVE OXYGEN TENSION - EFFECT OF INTRAOCULAR PRESSURE AND GLAUCOMA MEDICATION
E. Stefansson, Iceland
 
10:55  EFFICIACY REVIEW OF GLAUCOMA AGENTS IN CLINICAL PRACTICE
V.P. Costa, Brazil
 
11:15  OCULAR BLOODFLOW: THE HUMAN EXPERIENCE
A. Harris, -USA
 
11:35  VASCULAR RISK FACTORS FOR GLAUCOMA AND RELATED THERAPEUTIC IMPLICATIONS
J. Flammer, Switzerland
 
11:50  PANEL DISCUSSION  
12:00  Lunch Break  
13:00-14:30
NEUROPROTECTION
Chairperson: 
L.A.Levin, USA
Co -Moderators:
J.P.L Nordmann, France
P. Rozsival, Czech Republic
Hall A
13:00  TNF-ALPHA: A NEW VILLAIN IN GLAUCOMATOUS NEURODEGENERATION
M.B. Wax, G. Tezel, USA
 
13:11  GENE DELIVERY TO RETINAL GANGLION CELLS IN CULTURE USING FELINE IMMUNODEFICIENCY VIRUS
M. Good, USA
 
13:22  REDUCED REDOX STATE ALLOWS PROLONGED SURVIVAL OF AXOTOMIZED RETINAL GANGLION CELLS
L.A. Levin, USA
 
13:33  RETINAL GANGLION CELL SURVIVAL AFTER TRANSIENT ISCHEMIA INDUCED BY SELECTIVE LIGATURE OF THE OPHTHALMIC VESSELS: NEUROPROTECTIVE EFFECTS OF BRIMONIDINE
M. Vidal Sanz, M.P. Villegas-Perez, M.P. Lafuente, M.E. Aguilera, S. Mayor-Torroglosa, A. Garcia, J. Miralles De Imperial, Spain
 
13:40  ALPHA-2 AGONISTS, NEUROPROTECTION AND GLAUCOMA.
L. Wheeler, USA
 
13:47  SODIUM CHANNEL EFFECTS OF BETA-BLOCKERS SUGGEST THAT THEY CAN PROTECT THE OPTIC NERVE FROM ISCHAEMIC INJURY
N.N. Osborne, J. Melena, G. Chidlow, UK
 
13:54  EFFECT OF GINGKO BILOBA ON THE OUTCOME OF VISUAL FIELDS OF PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA
R. Vessani, Brazil
 
14:01  INTRAMUSCULARLY ADMINISTERED CYTIDIN-5'-DIPHOSPOCHOLINE IN GLAUCOMATOUS PATIENTS
F. Degregorio, J. Pecori Giraldi, J. Angelini, M. Palmieri, M. Virno, Italy
 
14:08  OAGD OPTIC NEUROPATHY AND RETINAL GANGLION CELL DAMAGE DUE TO IMPAIRMENT OF LAMINA CRIBROSA CIRCULATION (DESCENDING MODE), OR ALSO DIRECTLY TO THE MECHANICAL PRESSURE-EFFECT OF IOP (ASCENDING MODE)
A. Neetens, Belgium
 
14:15  Discussion  
14:30-16:00
IMAGING I
Co Sponsored by Heidelberg; Humphrey; Laser Diagnostic; Talia Technology
Chairpersons:
J. Schuman, USA
R.N.Weinreb, USA
Co-Moderators:
J. Airaksinen, Finlan
G. Hollo, Hungary
Hall A
14:30  ULTRAHIGH RESOLUTION OPTICAL COHERENCE TOMOGRAPHY
J.G. Fujimoto, W. Drexler, I. Hartl, T. Ko, R. Ghanta, J.S. Schuman, S. Bursell, USA
 
14:45  A COMPARISION OF NORMAL, GLAUCOMA SUSPECT, AND GLAUCOMA PATIENTS USING SELECTED HEIDELBERG RETINA TOMOGRAPH (HRT) PARAMETERS
K.S. Kooner, USA
 
14:53  STUDY OF RETINAL NERVE FIBER LAYER THICKNESS IN EYES WITHHIGH-TENSION GLAUCOMA AND HEMIFIELD DEFECT
M. Kook, Korea
 
15:01  OPTICAL COHERENCE TOMOGRAPHY VERSUS SEMIQUANTITATIV RED FREE PHOTOGRAPHY IN GLAUCOMA
M. Soliman, The Netherlands
 
15:09  LONGITUDINAL STUDY OF SCANNING LASER POLARIMETRY: COMPARISON TO AUTOMATED PERIMETRY
N.T. Choplin, USA
 
15:17  RETINAL THICKNESS IN THE MACULAR REGION: DIFFERENCES BETWEEN NORMAL AND GLAUCOMATOUS EYES
S. Vitale, R. Zeimer, S. Asrani, T. Dietrich, U. Schiefer, USA
 
15:25  PARAFOVEAL SCANNING LASER POLARIMETRY FOR DETECTION OF GLAUCOMA CHANGES
S. Kogure, H. Iijima, S. Tsukahara, Japan
 
15:33  COMPARING STRUCTURAL AND FUNCTIONAL TECHNIQUES FOR DETECTING GLAUCOMA
L. Zangwill, C. Bowd, C.C. Berry, E.Z. Blumenthal, C. Vasile, P.A. Sample, R.N. Weinreb, USA
 
15:41  CORRELATION BETWEEN RETINAL THICKNESS ANALYSIS, VISUAL FIELD CHANGES AND OPTIC NERVE CUPPING IN GLAUCOMA AND SUSPECTS
S. Asrani, USA
 
15:49 STABILITY OF CORNEALPOLARIZATION AXIS MEASUREMENTS FOR SCANNING LASER POLARIMETRY
D.S. Greenfield, USA
 
16:00  Coffee Break  
14:30-16:00
 
SURGERY II - IMPLANTS, ADJUNCTS, COMBINED
Chairperson: 
M.B.Sherwood, USA
Co-Moderators:
I. Liehneeva, Czech Republic
P. Rojanapongpun, Thailand
Hall B
14:30  LONG-TERM ANALYSIS OF TUBE SHUNTS IN REFRACTORY GLAUCOMA
J.L. Katz, USA
 
14:38  DEEP SCLERECTOMY WITH AND WITHOUT AN IMPLANT
T. Shaarawy, Switzerland
 
14:46  THE EX-PRESS MINIATURE GLAUCOMA IMPLANT: INTERMIDIETE RESULTS OF A PROSPECTIVE MULTICENTER STUDY.
C.E. Traverso, Italy
 
14:54  NON PENETRATIING DEEP SCLERECTOMY (NPDS) WITH SKGEL IMPLANT AND/OR 5 FLUOROURACILE (5-FU)
M. Detry-Morel, Belgium
 
15:02  SCLEROTRABECULECTOMY IN A COMBINATION WITH DRAINAGE OF SUPRACHOROIDAL SPACE IN GLUCOMA SURGERY
L.M. Balashova, M.S. Aronskind, A.V. Irhina, Russia
 
15:10  COMBINED PHACOEMULSIFICATION, INTRAOCULAR LENS IMPLANTATION AND TRABECULECTOMY FOR PRIMARY ANGLE CLOSURE GLAUCOMA
T. Aung, UK
 
15:18  COMPARISON OF NON_PENETRATING DEEP SCLERECTOMY WITH AND WITHOUT A RETICULATED HYALURONIC ACID IMPLANT
I. Liehneova, Czech Republic
 
15:26  GLAUCOMA DRAINAGE DEVICE AND PENETRATING KERATOPLASTY: GRAFT SURVIVAL AND IOP CONTROL.
F. Fantes, USA
 
15:34  EXPERIENCE WITH THE CZECH GLAUCOMA SILICONE IMPLANT (GSI) IN MULTICENTRIC STUDY
H. Kraus, Czech Republic
 
15:42  COMBINED SURGERY COMPARATIVE RESULTS OF PHACO-NPDS VERSUS PHACO-TRABECULECTOMY
A.F. Gonella, Argentina
 
15:50  Discussion  
16:00  Coffee Break  
16:30-18:30
VALVE COURSE
Chairpersons:
J. Freedman, USA
A. Molteno, New Zealand
Hall A
16:30  OVERVIEW OF VALVES GOALS AND INDICATIONS
J. Freedman, USA
 
16:45  PREVENTION OF HYPOTONY AND MANAGEMENT OF THE TUBE. DIFFERENT IMPLANTS, ADVANTAGES AND DISADVANTAGES.
M.B. Sherwood, USA
 
17:00  IMPLANTS IN MANAGEMENT OF NEOVASCULAR GLAUCOMA APHAKIC GLAUCOMA AND CORNEAL TRANSPLANTS
J. Freedman, USA
 
17:15  THE USE OF MOLTENO IMPLANTS TO INVESTIGATE THE PATHOPHYSIOLOGY OF BLEB FORMATION: APPLICATION TO CLINICAL PRACTISE
A. Molteno, New Zealand
 
17:55  Discussion  
16:30-18:00 
MECHANISMS
Sponsored by Santen
Chairperson:
C.E. Traverso, Italy
Co- Moderator:
J.B. Jonas, Germany
Hall B
16:30  RELATIONSHIP BETWEEN ACCOMODATION CONTRACTION AND AQUEOUS OUTFLOW IN PRIMARY OPEN ANGLE GLAUCOMA
T. Yamanaka, Japan
 
16:37  SUSTAINED ELEVATED INTRAOCULAR PRESSURE INFLUENCES OUTFLOW FACILITY IN PERFUSED HUMAN ANTERIOR SEGMENTS.
T. Borras, D. Epstein, USA
 
16:44  MECHANISM OF ACTION OF AGN 192024, A NEW OCULAR HYPOTENSIVE AGENT
R.F. Brubaker, USA
 
16:51  SILDENAFIL CITRATE (VIAGRA) DOES NOT SIGNIFICANTLY AFFECT THE INTRAOCULAR PRESSURE IN GLAUCOMA PATIENTS
J. Grunwald, USA
 
16:58  EFFECT OF LATANOPROST AND TIMOLOL ON THE HISTOPATHOLOGY OF THE RABBIT CONJUNCTIVA
H.F. Mietz, Germany
 
17:05  ANGLE CLOSURE GLAUCOMA: CONTROVERSIES IN THE PUPILLARY BLOCK MECHANISM STUDIED BY UBM
N. Calixto, S. Cronemberger, A. Andrade, J.M. Calixto, Brazil
 
17:12  GLAUCOMA DIAGNOSIS FOLLOWING LASIK
R.A. Lewis, USA
 
17:19  ARE OPTIC DISC SIZE AND SHAPE RISK FACTORS FOR PROGRESSION OF GLAUCOMA ?
J.B. Jonas, J.K. Hayler, A. Juenemann, W.M. Budde, P. Martus, Germany
 
17:26  DIURNAL CHANGES OF THE OPTIC DISC
A. Wegner, Germany
 
17:33  OCULAR HEMODYNAMICS IN NORMAL PRESSURE GLAUCOMA PATIENTS WITH DISC HEMORRHAGES
L.E. Pillunat, Germany
 
17:47  Discussion  

top


D E S I G N E D  B Y

atartica.gif (1865 bytes)